iQSTEL vs SurgePays
IQST and SURG side by side, both in telephone communications. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IQST and SURG compare
iQSTEL is the larger company, worth 38 times as much as SurgePays ($278M against $7.2M).
iQSTEL keeps more of each dollar of sales as profit, with a net margin of −2.2% compared with −47.9% at SurgePays.
iQSTEL scores higher on the StockData Score (6 against 1 for SurgePays), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IQST | SURG |
|---|---|---|
| Size and price | ||
| Market cap | $278M | $7.2M |
| Share price | $0.690 | $0.137 |
| Change, 1 year | −86.6% | −93.2% |
| Change, 5 years | −98.3% | −94.3% |
| Beta (5Y) | 0.97 | 2.51 |
| Employees | 100 | 30 |
| StockData Score | ||
| Total score | 6 (better) | 1 |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 (better) | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 3 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.7× | 0.1× (better) |
| P/B | 16.2× | – |
| FCF yield | −1.4% | – |
| Growth | ||
| Revenue growth (TTM) | 39.3% | – |
| Revenue growth, 5Y average | 37.4% (better) | 0.92% |
| Profitability | ||
| Gross margin | 2.7% (better) | −19.6% |
| Operating margin | −1.3% (better) | −41.0% |
| Net margin | −2.2% (better) | −47.9% |
| FCF margin | −0.99% | – |
| Return on equity | −56.0% | – |
| Return on invested capital | −23.3% | – |
| Financial health | ||
| Debt / equity | 0.15 | – |
| Interest coverage | – | −15.3× |
| Current ratio | 1.09 (better) | 0.19 |
| Altman Z-score | 11.90 (better) | −21.51 |
| Piotroski F-score | 3 | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 0.06% | 4.4% |
| Held by insiders | 0.00% | 9.2% |
| Insider net buying, 12 months | – | $83.0K |
| Short interest, % of float | 0.10% | 9.1% |
Go deeper
- IQST stock overview
- IQST income statement
- IQST valuation and score
- SURG stock overview
- SURG income statement
- SURG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.